Mark W Hahn Verona Pharma PLC (VRNA) insider trading activity
Mark W Hahn is Chief Financial Officer of Verona Pharma plc. Currently has a direct ownership of 13.3 Million shares of VRNA, which is worth approximately $822 Million. The most recent transaction as insider was on Nov 02, 2021, when has been sold 10,416 shares (Ordinary Shares) at a price of $0.65 per share, resulting in proceeds of $6,770. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
13.3M
6.75%
3M change
11.34%
12M change
Total Value Held
$822 Million
Mark W Hahn Transaction History
MWH
Mark W Hahn
Chief Financial Officer
London, X0